| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |